CCR1 and cancer: We also speculate that in vivo endemic BL cells expressing CCR1 are prone to migrate toward ligand-expressing immune cells and ligand-rich blood organs, and therefore, in an immunocompromised state, dissemination of malignant cells may contribute to the pathogenesis of this cancer.